@article{513b908a795d48518b2ede08be1a44c0,
title = "Medication Treatment for Opioid-Addicted Youth—What Are We Waiting for?",
author = "Woody, {George E.} and Marc Fishman",
note = "Funding Information: Drs. Woody and Fishman have received in-kind buprenorphine-naloxone and extended release injectable naltrexone as part of NIDA-funded treatment studies. Dr. Woody has been a consultant to Alkermes and Dr. Fishman has been a consultant for Alkermes and US World Meds.",
year = "2020",
month = jul,
doi = "10.1016/j.jadohealth.2020.04.002",
language = "English (US)",
volume = "67",
pages = "9--10",
journal = "Journal of Adolescent Health",
issn = "1054-139X",
publisher = "Elsevier USA",
number = "1",
}